Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pragmatic Randomized Trial of Risperdal Consta Versus Oral Atypical Antipsychotics in Poorly Adherent Subjects With Schizophrenia in a Routine Care Setting

NCT00256997 is registered in ClinicalTrials.gov with Janssen-Ortho Inc., Canada as lead sponsor.

NCT NCT00256997
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00256997 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pragmatic Randomized Trial of Risperdal Consta Versus Oral Atypical Antipsychotics in Poorly Adherent Subjects With Schizophrenia in a Routine Care Setting
Lead sponsor
Janssen-Ortho Inc., Canada
Phase
Phase 4
Overall status
Terminated
Start date
January 31, 2006
Completion date
April 30, 2009
Enrollment
167 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia